Finance

Lists
CERS:NASDAQ
Cerus Corp
2,26 $
0,00%
(0,00) 1D
2,26 $
0,00% (0,00)
After hours
Closed: 13 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CERS...
Open
2,28 $
High
2,32 $
Low
2,24 $
Mkt. cap
455,45 մլն
Avg. vol.
1,64 մլն
Volume
2,29 մլն
52-wk high
3,47 $
52-wk low
1,38 $
EPS
-0,03 $
Beta
1,83
Shares outstanding
201,52 մլն
No. of employees
268
Open
2,28 $
High
2,32 $
Low
2,24 $
Mkt. cap
455,45 մլն
Avg. vol.
1,64 մլն
Volume
2,29 մլն
52-wk high
3,47 $
52-wk low
1,38 $
EPS
-0,03 $
Beta
1,83
Shares outstanding
201,52 մլն
No. of employees
268
News stories
From web sources and news partners
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
Foundedսեպ 1991
HeadquartersConcord, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitecerus.com
Analyst ratings
Based on 2 analysts giving stock ratings to CERS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CERS in the last 3 months.
Highest
Current 2,26 $
5,00 $ (+121,24%)
Average
4,50 $ (+99,12%)
Lowest
4,00 $ (+76,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
5,00 $
+121,2%
08/28/2026
Mark Massaro
BTIG
Buy
Reiterated
4,00 $
+77%
08/14/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
52,70 մլն
57,75 մլն
53,66 մլն
57,44 մլն
Cost of goods sold
24,56 մլն
28,00 մլն
25,77 մլն
27,91 մլն
Cost of revenue
24,56 մլն
28,00 մլն
25,77 մլն
27,91 մլն
Research and development expenses
15,82 մլն
16,39 մլն
14,53 մլն
14,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,62 մլն
20,83 մլն
19,95 մլն
22,86 մլն
Operating expense
26,90 մլն
30,39 մլն
28,25 մլն
31,39 մլն
Total operating expenses
51,46 մլն
58,39 մլն
54,02 մլն
59,30 մլն
Operating income
1,24 մլն
-641,00 հզր
-354,00 հզր
-1,86 մլն
Other non operating income
976,00 հզր
578,00 հզր
520,00 հզր
734,00 հզր
EBT including unusual items
65,00 հզր
-2,06 մլն
-1,56 մլն
-2,89 մլն
EBT excluding unusual items
65,00 հզր
-2,08 մլն
-1,56 մլն
-2,89 մլն
Income tax expense
85,00 հզր
119,00 հզր
91,00 հզր
95,00 հզր
Effective tax rate
130,77%
-5,76%
-5,84%
-3,29%
Other operating expenses
-7,54 մլն
-6,83 մլն
-6,23 մլն
-5,86 մլն
Net income
-19,00 հզր
-2,18 մլն
-1,64 մլն
-2,94 մլն
Net profit margin
-0,04%
-3,78%
-3,06%
-5,12%
Earnings per share
-
-0,01
-0,01
-0,01
Interest and investment income
-
-
-
-
Interest expense
-2,12 մլն
-1,96 մլն
-1,87 մլն
-1,71 մլն
Net interest expenses
-2,12 մլն
-1,96 մլն
-1,87 մլն
-1,71 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,62 մլն
-248,00 հզր
93,00 հզր
-1,40 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps